Jessica Fees, See Remarks at Surface Oncology, Inc. (SURF), sold 1,500 shares at $12.45 ($19K) on 2021-02-08, disclosed to the SEC on 2021-02-09.
Scheduled sale ($19k) by See Remarks under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| SURF | SELL | 2022-01-14 | $242K | — | Filing → |
| SURF | SELL | 2021-02-03 | $17K | — | Filing → |